Logo image of BXC

BLUELINX HOLDINGS INC (BXC) Stock Fundamental Analysis

NYSE:BXC - New York Stock Exchange, Inc. - US09624H2085 - Common Stock - Currency: USD

65.16  -1.35 (-2.03%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BXC. BXC was compared to 48 industry peers in the Trading Companies & Distributors industry. BXC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BXC has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BXC had positive earnings in the past year.
In the past year BXC had a positive cash flow from operations.
Each year in the past 5 years BXC has been profitable.
In the past 5 years BXC always reported a positive cash flow from operatings.
BXC Yearly Net Income VS EBIT VS OCF VS FCFBXC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

BXC has a Return On Assets of 2.35%. This is comparable to the rest of the industry: BXC outperforms 41.67% of its industry peers.
BXC has a Return On Equity of 6.04%. This is in the lower half of the industry: BXC underperforms 66.67% of its industry peers.
BXC has a worse Return On Invested Capital (3.49%) than 72.92% of its industry peers.
BXC had an Average Return On Invested Capital over the past 3 years of 11.49%. This is above the industry average of 9.18%.
The last Return On Invested Capital (3.49%) for BXC is well below the 3 year average (11.49%), which needs to be investigated, but indicates that BXC had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.35%
ROE 6.04%
ROIC 3.49%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
BXC Yearly ROA, ROE, ROICBXC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

BXC has a worse Profit Margin (1.31%) than 70.83% of its industry peers.
BXC's Profit Margin has declined in the last couple of years.
BXC has a Operating Margin of 2.40%. This is in the lower half of the industry: BXC underperforms 75.00% of its industry peers.
BXC's Operating Margin has improved in the last couple of years.
The Gross Margin of BXC (16.10%) is worse than 89.58% of its industry peers.
In the last couple of years the Gross Margin of BXC has grown nicely.
Industry RankSector Rank
OM 2.4%
PM (TTM) 1.31%
GM 16.1%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
BXC Yearly Profit, Operating, Gross MarginsBXC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

7

2. Health

2.1 Basic Checks

BXC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for BXC has been reduced compared to 1 year ago.
BXC has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, BXC has an improved debt to assets ratio.
BXC Yearly Shares OutstandingBXC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
BXC Yearly Total Debt VS Total AssetsBXC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

BXC has an Altman-Z score of 3.36. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, BXC is in the better half of the industry, outperforming 64.58% of the companies in the same industry.
BXC has a debt to FCF ratio of 14.64. This is a negative value and a sign of low solvency as BXC would need 14.64 years to pay back of all of its debts.
BXC has a Debt to FCF ratio (14.64) which is in line with its industry peers.
BXC has a Debt/Equity ratio of 0.94. This is a neutral value indicating BXC is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.94, BXC is not doing good in the industry: 60.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.64
Altman-Z 3.36
ROIC/WACC0.37
WACC9.45%
BXC Yearly LT Debt VS Equity VS FCFBXC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

BXC has a Current Ratio of 4.16. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
BXC has a Current ratio of 4.16. This is amongst the best in the industry. BXC outperforms 87.50% of its industry peers.
A Quick Ratio of 2.73 indicates that BXC has no problem at all paying its short term obligations.
BXC has a better Quick ratio (2.73) than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.16
Quick Ratio 2.73
BXC Yearly Current Assets VS Current LiabilitesBXC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for BXC have decreased strongly by -58.89% in the last year.
BXC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -40.26% yearly.
Looking at the last year, BXC shows a decrease in Revenue. The Revenue has decreased by -4.22% in the last year.
BXC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.28% yearly.
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%

3.2 Future

The Earnings Per Share is expected to decrease by -11.93% on average over the next years. This is quite bad
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BXC Yearly Revenue VS EstimatesBXC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
BXC Yearly EPS VS EstimatesBXC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2019 2020 2021 2022 2023 2024 2025 2026 0 10 20 30

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.45, BXC is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a somewhat cheap valuation: BXC is cheaper than 77.08% of the companies listed in the same industry.
BXC is valuated rather cheaply when we compare the Price/Earnings ratio to 25.91, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.17, the valuation of BXC can be described as correct.
BXC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BXC is cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.85. BXC is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 14.45
Fwd PE 13.17
BXC Price Earnings VS Forward Price EarningsBXC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BXC is valued cheaply inside the industry as 87.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BXC indicates a rather cheap valuation: BXC is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.5
EV/EBITDA 6.39
BXC Per share dataBXC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

BXC's earnings are expected to decrease with -11.93% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.93%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for BXC!.
Industry RankSector Rank
Dividend Yield N/A

BLUELINX HOLDINGS INC

NYSE:BXC (5/23/2025, 11:58:11 AM)

65.16

-1.35 (-2.03%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners93.76%
Inst Owner Change6.75%
Ins Owners2.01%
Ins Owner Change0.01%
Market Cap522.58M
Analysts80
Price Target93.08 (42.85%)
Short Float %3.16%
Short Ratio2.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.51%
Min EPS beat(2)0.88%
Max EPS beat(2)16.15%
EPS beat(4)3
Avg EPS beat(4)18.48%
Min EPS beat(4)-4.68%
Max EPS beat(4)61.56%
EPS beat(8)6
Avg EPS beat(8)24.8%
EPS beat(12)9
Avg EPS beat(12)17.26%
EPS beat(16)13
Avg EPS beat(16)31.96%
Revenue beat(2)1
Avg Revenue beat(2)-0.61%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)0.42%
Revenue beat(4)1
Avg Revenue beat(4)-1.39%
Min Revenue beat(4)-2.52%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-3.1%
Revenue beat(12)3
Avg Revenue beat(12)-3.04%
Revenue beat(16)7
Avg Revenue beat(16)1.85%
PT rev (1m)-25.81%
PT rev (3m)-32.66%
EPS NQ rev (1m)-31.1%
EPS NQ rev (3m)-50.12%
EPS NY rev (1m)-23.01%
EPS NY rev (3m)-50.48%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)-1.06%
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE 14.45
Fwd PE 13.17
P/S 0.18
P/FCF 12.5
P/OCF 6.34
P/B 0.82
P/tB 0.94
EV/EBITDA 6.39
EPS(TTM)4.51
EY6.92%
EPS(NY)4.95
Fwd EY7.6%
FCF(TTM)5.21
FCFY8%
OCF(TTM)10.27
OCFY15.77%
SpS366.02
BVpS79.32
TBVpS69.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.35%
ROE 6.04%
ROCE 5.2%
ROIC 3.49%
ROICexc 5.23%
ROICexgc 5.75%
OM 2.4%
PM (TTM) 1.31%
GM 16.1%
FCFM 1.42%
ROA(3y)8.8%
ROA(5y)11.32%
ROE(3y)22.02%
ROE(5y)56.9%
ROIC(3y)11.49%
ROIC(5y)14.44%
ROICexc(3y)16.25%
ROICexc(5y)17.76%
ROICexgc(3y)18%
ROICexgc(5y)19.38%
ROCE(3y)17.1%
ROCE(5y)21.48%
ROICexcg growth 3Y-37.08%
ROICexcg growth 5Y30.14%
ROICexc growth 3Y-37.9%
ROICexc growth 5Y30.02%
OM growth 3Y-33.48%
OM growth 5Y28.68%
PM growth 3Y-36.19%
PM growth 5YN/A
GM growth 3Y-3.08%
GM growth 5Y4.13%
F-Score4
Asset Turnover1.8
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 14.64
Debt/EBITDA 5.48
Cap/Depr 105.14%
Cap/Sales 1.38%
Interest Coverage 1.55
Cash Conversion 75.63%
Profit Quality 108.8%
Current Ratio 4.16
Quick Ratio 2.73
Altman-Z 3.36
F-Score4
WACC9.45%
ROIC/WACC0.37
Cap/Depr(3y)106.72%
Cap/Depr(5y)76.81%
Cap/Sales(3y)1.01%
Cap/Sales(5y)0.7%
Profit Quality(3y)260.74%
Profit Quality(5y)177.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-58.89%
EPS 3Y-40.26%
EPS 5YN/A
EPS Q2Q%-87.38%
EPS Next Y-51.28%
EPS Next 2Y-11.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y-11.62%
Revenue growth 5Y2.28%
Sales Q2Q%-2.34%
Revenue Next Year2.73%
Revenue Next 2Y3.86%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.36%
EBIT growth 3Y-41.21%
EBIT growth 5Y31.62%
EBIT Next Year27.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-90.6%
FCF growth 3Y-29.86%
FCF growth 5YN/A
OCF growth 1Y-83.08%
OCF growth 3Y-16.25%
OCF growth 5YN/A